Navigation Links
BioMS Medical Provides Update On Pipeline Products
Date:5/9/2008

entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to MBP8298 in exchange for an $87 million upfront payment, milestone payments and escalating royalties on sales. For further information please visit our website at http://www.biomsmedical.com.

This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that MBP8298 will continue to demonstrate a satisfactory safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioMS Medical announces conference call and web cast for Annual General Meeting
2. BioMS Medical to Participate in Speciality Panel Session at BioFinance 2008
3. BioMS Medical to present at EQUITIES Conference
4. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
5. BioMS Medical to present at BioCentury Conference
6. BioMS Medical Announces 2007 Year End Results
7. BioMS Medical to present at BIO CEO & Investor Conference
8. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
9. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
10. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
11. BioMS Medical announces third quarter 2007 results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015  Sonoa Health, a health tech startup ... developed a world-first consumer health portal, Health&, which brings ... devices and more. Today, the Company appointed ... CEO, who brings to the table more than 18-years ... included working closely with the biggest names in Silicon ...
(Date:3/31/2015)...  The Myeloma Crowd Research Initiative (MCRI) completed ... proposals that will now be evaluated for further ... validated funding initiative uncovering solutions for high-risk multiple ... MCRI included preliminary vetting by the Scientific Advisory ... of innovative projects focusing on high-risk myeloma, we ...
(Date:3/31/2015)... CA (PRWEB) March 31, 2015 This ... Professors from the top U.S and International Medical Schools ... their latest research on the application of stem cell ... The symposium is organized and funded by the ... nonprofit that has been convening intimate meetings of top ...
(Date:3/31/2015)... 31, 2015 Lighthouse Information Systems, ... operations in California, Oregon, Washington and clients across ... Merger and Acquisition (M&A) Integration Services offering, effective ... Client Services and M&A Integration Practice Leader at ... vast majority of M&A initiatives fail to achieve ...
Breaking Biology Technology:Investment Banker Appointed CEO of Australian Health Tech Start-Up 2Investment Banker Appointed CEO of Australian Health Tech Start-Up 3Myeloma Crowd Research Initiative Selects 10 High-Risk Multiple Myeloma Proposals For Further Review 2Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2Lighthouse Information Systems, Inc., Announces Addition of M&A Integration Services 2
... Hagens, BODY WORLDS 2:,The Original Exhibition of Real ... this Saturday, February 2nd. The acclaimed exhibition,includes the ... a special feature on,the brain., BODY WORLDS ... healthy and unhealthy organs, body section and slices, ...
... Feb. 1 ,Genzyme Corp. (Nasdaq: GENZ ) and ... they have received clearance under the,Hart-Scott-Rodino Antitrust Improvements Act ... Based on this approval, Genzyme will pay,Isis $150 million ... for,$30 per share., Upon completion of final contracts, ...
... Therapeutics (Amex:,CXM) announced that it has completed ... and other accredited or qualified investors,that was ... Asset Management,Company acted as the sole placement ... http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ), The securities were offered ...
Cached Biology Technology:Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2 2Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration 2Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration 3Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration 4Cardium Completes $5.3 Million Registered Direct Offering 2Cardium Completes $5.3 Million Registered Direct Offering 3Cardium Completes $5.3 Million Registered Direct Offering 4
(Date:3/23/2015)... Mass , March 23, 2015 SoundView Technology ... of NXT-ID,s (NASDAQ: NXTD ) Wocket smart wallet. SoundView was ... user feedback on their experience with the Wocket in multiple ... at CVS, Whole Foods and other retailers, making both debit ... Kris Tuttle also says, "If the company meets their ...
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced ... Business Report" report to their offering. This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the ...
(Date:3/17/2015)... 2015 MedNet Solutions , a ... study management systems, is pleased to announce that ... Outsourcing in Clinical Trials Southeast conference – March ... excellent forum for MedNet to showcase iMedNet ... (SaaS) eClinical technology platform. We strongly ...
Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... of mythological beliefs. Some cultures prize them for their ... as dagger handles or good luck charms. But new ... by explaining how the horn gets its distinctive curve ... details about the structural materials that form the horn ...
... of Michigan Medical School have discovered a previously unknown ... and renal failure in children: recessive mutations in a ... the mutant gene is important to scientists because PLCE1 ... a vital role in the kidney's ability to remove ...
... found that aged mice undergoing weekly light-cycle shifts--similar to ... shift work--experienced significantly higher death rates than did old ... same eight-week period. The findings may not come as ... the research nonetheless provides, in rather stark terms, new ...
Cached Biology News:Scientists crack rhino horn riddle 2Mutant gene causes severe kidney disease in infants 2Mutant gene causes severe kidney disease in infants 3Mutant gene causes severe kidney disease in infants 4Chronic jet-lag conditions hasten death in aged mice 2
MAb to Vasopressin Preservative: NaN3...
... GenBank Accession Number : NM_002542 Immunogen ... corresponding to residues 166-223 of human AP-2α ... 0.1M Tris-glycine, pH 7.4, 0.15M NaCl, 0.05% ... to 30% Quality Assurance: routinely evaluated by ...
Mouse monoclonal [1C6/2] to Rad17 ( Abpromise for all tested applications). entrezGeneID: 5884 SwissProtID: Q9UPF5...
MMP-2 / MMP-9 Inhibitor IV is a potent, selective, slow binding and mechanism based inhibitor of human gelatinases. • Molecular weight: 306.4 • Molecular Formula: C(15)H(14)O(3)S(2). &bul...
Biology Products: